Skip to main content
. 2022 Oct 20;22:384–403. doi: 10.1016/j.bioactmat.2022.10.006

Table 2.

A summary of cell viability (cytotoxicity) at each time point (7 or 14 days) or solution concentrations (5%, 10%, and 20% vol/vol) of different clear aligner materials.

Brand Category Composition Cell viability (%) Days or final solution concentration (% v/v) Cytotoxicity
Duran [104]
(Scheu-Dental GmbH, Iserlohn, Germany)
Thermoformed Polyethylen terephthalate glycol
(PETG)
84.6 ± 4.02 14 days Slight
Biolon
(Dreve Dentamid GmbH, Unna, Germany)
Thermoformed Polyethylene terephthalate glycol
(PETG)
64.6 ± 3.31 14 days Slight
Zendura
(Bay Materials LLC, Fremont, CA, USA)
Thermoformed Polyurethane resin
(PU)
74.4 ± 2.34 14 days Slight
SmartTrack™
(Align Tech, San Jose, CA, USA)
Thermoformed Multilayer aromatic thermoplastic polyurethane/copolyester 78.8 ± 6.35 14 days Slight
E-Guard [106]
(EnvisionTEC, Rockhill, SC, USA)
3D printed Photopolymer 75.06 ± 8.98 7 days Slight
Dental LT
(Formlabsinc)
3D printed Photopolymer 77.74 ± 3.22 7 days Slight
SmartTrack™
(Align Tech, San Jose, CA, USA)
Thermoformed Multilayer aromatic thermoplastic polyurethane/copolyester 94.07 ± 3.00 7 days No
TC85A [107]
(Graphy, Seoul, South Korea)
3D printed Photopolymerizable polyurethane 97.6 ± 14.6
98.3 ± 15.9
92.0 ± 13.0
5%  4
10%  8
20%  h
No
No
No
SmartTrack™ [108]
(Align Tech, San Jose, CA, USA)
Thermoformed Polyurethane 82.6 ± 13.6
60.3 ± 8.8
54.5 ± 23.1
5%  7
10%  2
20%  h
Slight
Slight
Moderate
Eon
(Eon Holding, Amman, JO)
Thermoformed Polyurethane resin
(PU)
85.1 ± 18.3
54.8 ± 16.8
60.4 ± 20.7
5%
10%
20%
Slight
Moderate
Slight
Suresmile
(Dentsply-Sirona, Charlotte, NC, USA)
Thermoformed Polyurethane resin
(PU)
85.4 ± 16.4
70.7 ± 15.8
56.8 ± 11.3
5%
10%
20%
Slight
Slight
Moderate
Clarity
(3 M, St Paul, MN, USA)
Thermoformed Polyurethane resin
(PU)
89.3 ± 15.0
72.9 ± 21.1
71.8 ± 15.4
5%
10%
20%
Slight
Slight
Slight

Cytotoxicity: No, cell viability more than 90%; Slight, cell viability 60%–90%; Moderate, cell viability 30%–59%; Severe, cell viability less than 30%.